THE ROLE AND SIGNIFICANCE OF THE KI67 PROLIFERATION MARKER IN DIFFERENTIATED THYROID CARCINOMA

dc.contributor.authorM.S. Khudayorov
dc.contributor.authorO.B. Abdurakhmonov
dc.contributor.authorD.A. Nishanov
dc.contributor.authorA.A. Madaliyev
dc.contributor.authorU.A. Soatov
dc.date.accessioned2025-12-31T15:41:45Z
dc.date.issued2025-12-16
dc.description.abstractThis article presents data from literature sources regarding the epidemiology, diagnosis, and treatment methods of differentiated thyroid carcinoma. The Ki67 proliferation marker was evaluated in tissue samples from 20 patients with differentiated thyroid carcinoma. The results of the immunohistochemical analysis were assessed based on the intensity of the positive reaction — mild, moderate, and high. The study describes the percentage distribution of patients showing different levels of Ki67 expression
dc.formatapplication/pdf
dc.identifier.urihttps://scholarexpress.net/index.php/wbph/article/view/5725
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/50090
dc.language.isoeng
dc.publisherScholar Express Journals
dc.relationhttps://scholarexpress.net/index.php/wbph/article/view/5725/4843
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWorld Bulletin of Public Health; Vol. 53 (2025): WBPH; 16-19
dc.source2749-3644
dc.subjectDifferentiated thyroid carcinoma
dc.subjectimmunohistochemistry
dc.subjectKi67
dc.subjectproliferative activity
dc.titleTHE ROLE AND SIGNIFICANCE OF THE KI67 PROLIFERATION MARKER IN DIFFERENTIATED THYROID CARCINOMA
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
khudayorov_2025_the_role_and_significance_of_the_ki67_pr.pdf
item.page.filesection.size
339.11 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections